Randomized Teriparatide [Human Parathyroid Hormone (PTH) 1–34] Once-Weekly Efficacy Research (TOWER) Trial for Examining the Reduction in New Vertebral Fractures in Subjects with Primary Osteoporosis and High Fracture Risk-Reference-Cited by-同舟云学术

Randomized Teriparatide [Human Parathyroid Hormone (PTH) 1–34] Once-Weekly Efficacy Research (TOWER) Trial for Examining the Reduction in New Vertebral Fractures in Subjects with Primary Osteoporosis and High Fracture Risk

Published:2012-09-01 Issue:9 Volume:97 Page:3097-3106
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

Nakamura Toshitaka¹,Sugimoto Toshitsugu²,Nakano Tetsuo³,Kishimoto Hideaki⁴,Ito Masako⁵,Fukunaga Masao⁶,Hagino Hiroshi⁷,Sone Teruki⁸,Yoshikawa Hideki⁹,Nishizawa Yoshiki¹⁰,Fujita Takuo¹¹,Shiraki Masataka¹²

Affiliation:

1. Department of Orthopedic Surgery (T.Nakam.), University of Occupational and Environmental Health, Kitakyushu 807-8555, Japan

2. Internal Medicine 1 (T.Su.), Shimane University Faculty of Medicine, Izumo 693-8501, Japan

3. Tamana Central Hospital (T.Nakan.), Tamana 865-0064, Japan

4. Sanin Rosai Hospital (H.K.), Yonago 683-8605, Japan

5. Division of Radiology (M.I.), Nagasaki University School of Medicine, Nagasaki 852-8501, Japan

6. Kawasaki Medical School (M.F.), Kurashiki 701-0192, Japan

7. School of Health Science & Rehabilitation Division (H.H.), Faculty of Medicine, Tottori University, Yonago 683-8503, Japan

8. Department of Radiology (T.So.), Division of Nuclear Medicine, Kawasaki Medical School, Kurashiki 701-0192, Japan

9. Department of Orthopedic Surgery (H.Y.), Osaka University Graduate School of Medicine, Suita 565-0871, Japan

10. Osaka City University (Y.N.), Osaka 558-8585, Japan

11. Katsuragi Hospital (T.F.), Kishiwada 590-0842, Japan

12. Research Institute and Practice for Involutional Diseases (M.S.), Azumino 399-8101, Japan

Publisher

The Endocrine Society

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jcem/article-pdf/97/9/3097/9047302/jcem3097.pdf

Reference32 articles.

1. Epidemiology and outcome of osteoporotic fractures.;Cummings;Lancet,2002

2. The effect of teriparatide [human parathyroid hormone (1–34)] therapy on bone density in men with osteoporosis.;Orwoll;J Bone Miner Res,2003

3. Effects of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis.;Neer;N Engl J Med,2001

4. Effects of teriparatide on bone mineral density and biochemical markers in Japanese subjects with osteoporosis at high risk of fracture in a 24-month clinical study: 12-month, randomized, placebo-controlled, double-blind and 12-month open-label phases.;Miyauchi;Bone,2010

5. Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study.;Dempster;J Bone Miner Res,2001

Cited by 222 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of daily teriparatide, weekly high-dose teriparatide, or bisphosphonate on cortical and trabecular bone of vertebra and proximal femur in postmenopausal women with fragility fracture: Sub-analysis by quantitative computed tomography from the TERABIT study;Bone;2024-10

2. Discovery of Novel Antiosteoporosis Leads with Bone Resorption Inhibition and Anabolic Promotion through a Chemotype-Assembly Approach;Journal of Medicinal Chemistry;2024-08-21

3. Independent Risk Factors of Proximal Junctional Kyphosis with Vertebral Fracture After Spinal Long Fusion: Survivorship Analysis of Adult Spinal Deformity Surgery Patients;World Neurosurgery;2024-08

4. Clinical effects of teriparatide, abaloparatide, and romosozumab in postmenopausal osteoporosis;Journal of Bone and Mineral Metabolism;2024-07-15

5. Effects of differences in dose and frequency of teriparatide on bone structure in Proximal Femur. – Analysis by DXA-based 3D-modeling (3D-SHAPER Software) –TRIPLE-BONE study (The effects of TeRIParatide preparation on bone mineraL density increase and BONE structure);Archives of Osteoporosis;2024-07-02